Literature DB >> 30048823

Autism spectrum disorder in females with ARHGEF9 alterations and a random pattern of X chromosome inactivation.

Mahmoud Aarabi1, Elena Kessler2, Suneeta Madan-Khetarpal2, Urvashi Surti3, Daniel Bellissimo1, Aleksandar Rajkovic4, Svetlana A Yatsenko5.   

Abstract

Proper function of GABAergic synapses depends upon the postsynaptic compartment anchoring of neurotransmitter receptors to the membrane by gephyrin and collybistin (Cb). In humans, Cb is encoded by ARHGEF9 on Xq11.1. ARHGEF9 alterations, some inherited from unaffected mothers, have been reported in males with autism, seizures and severe neurodevelopmental abnormalities. In females, a spectrum of mild to moderate phenotype has been detected. We report two unrelated females with autism and mild intellectual disability. High resolution X-chromosome microarray analysis revealed de novo intragenic deletions in ARHGEF9 of 24 kb and 56 kb involving exons 5-8 and exons 3-8 and leading to truncated forms of collybistin. Peripheral blood samples revealed random X-chromosome inactivation in both patients. To explain phenotypic variability in female patients, we propose a model for disruption of collybistin and various irregular interactions in post-synaptic neurons based on X inactivation patterns. Our findings highlight the importance of ARHGEF9 integrity and suggest further research on its correlation with autism and neurobehavioral problems.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  ARHGEF9; Autism; Collybistin; Microdeletion; X-chromosome inactivation

Mesh:

Substances:

Year:  2018        PMID: 30048823     DOI: 10.1016/j.ejmg.2018.07.021

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  5 in total

1.  De novo ARHGEF9 missense variants associated with neurodevelopmental disorder in females: expanding the genotypic and phenotypic spectrum of ARHGEF9 disease in females.

Authors:  Marcello Scala; Evelien Zonneveld-Huijssoon; Marianna Brienza; Oriano Mecarelli; Annemarie H van der Hout; Elena Zambrelli; Katherine Turner; Federico Zara; Angela Peron; Aglaia Vignoli; Pasquale Striano
Journal:  Neurogenetics       Date:  2020-09-17       Impact factor: 2.660

2.  Mutation p.R356Q in the Collybistin Phosphoinositide Binding Site Is Associated With Mild Intellectual Disability.

Authors:  Tzu-Ting Chiou; Philip Long; Alexandra Schumann-Gillett; Venkateswarlu Kanamarlapudi; Stefan A Haas; Kirsten Harvey; Megan L O'Mara; Angel L De Blas; Vera M Kalscheuer; Robert J Harvey
Journal:  Front Mol Neurosci       Date:  2019-03-12       Impact factor: 5.639

3.  Human ARHGEF9 intellectual disability syndrome is phenocopied by a mutation that disrupts collybistin binding to the GABAA receptor α2 subunit.

Authors:  Dustin J Hines; April Contreras; Betsua Garcia; Jeffrey S Barker; Austin J Boren; Christelle Moufawad El Achkar; Stephen J Moss; Rochelle M Hines
Journal:  Mol Psychiatry       Date:  2022-02-15       Impact factor: 13.437

4.  ARHGEF9 gene variant leads to developmental and epileptic encephalopathy: Genotypic phenotype analysis and treatment exploration.

Authors:  Haiyan Yang; Hongmei Liao; Siyi Gan; Ting Xiao; Liwen Wu
Journal:  Mol Genet Genomic Med       Date:  2022-05-31       Impact factor: 2.473

Review 5.  Rho GTPase Regulators and Effectors in Autism Spectrum Disorders: Animal Models and Insights for Therapeutics.

Authors:  Daji Guo; Xiaoman Yang; Lei Shi
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.